Vitamin D: Difference between revisions
Created page with "{{Short description|Group of fat-soluble secosteroids}} {{Infobox drug class |Synonyms= Calciferols | Image = Cholecalciferol2.svg | Alt = | Caption = Cholecalciferol (D<sub>3</sub>) | Use = Rickets, osteoporosis, vitamin D deficiency | MeshID = D014807 | Consumer_Reports = | ATC_prefix = A11CC | medicinenet = | rxlist = | Drugs.com = {{Drugs.com|npp|vitamin-d}} | Biological_target = vitamin D receptor }} '''Vitam..." |
|||
| Line 524: | Line 524: | ||
A meta-analysis of three studies on the effect of oral vitamin D or calcifediol supplementation indicated a lower [[intensive care unit]] (ICU) admission rate ([[odds ratio]]: 0.36) compared to those without supplementation, but without a change in mortality. A Cochrane review, also of three studies, found the evidence for the effectiveness of vitamin D supplementation for the treatment of COVID-19 to be very uncertain. They found there was substantial clinical and methodological heterogeneity in the three studies that were included, mainly because of different supplementation strategies, vitamin D formulations (one using calcifediol), pre-treatment status and reported outcomes. Another meta-analysis stated that the use of high doses of vitamin D in people with COVID-19 is not based on solid evidence although calcifediol supplementation may have a protective effect on ICU admissions. | A meta-analysis of three studies on the effect of oral vitamin D or calcifediol supplementation indicated a lower [[intensive care unit]] (ICU) admission rate ([[odds ratio]]: 0.36) compared to those without supplementation, but without a change in mortality. A Cochrane review, also of three studies, found the evidence for the effectiveness of vitamin D supplementation for the treatment of COVID-19 to be very uncertain. They found there was substantial clinical and methodological heterogeneity in the three studies that were included, mainly because of different supplementation strategies, vitamin D formulations (one using calcifediol), pre-treatment status and reported outcomes. Another meta-analysis stated that the use of high doses of vitamin D in people with COVID-19 is not based on solid evidence although calcifediol supplementation may have a protective effect on ICU admissions. | ||
{{Vitamins}} | {{Vitamins}} | ||